Advances in Biomarkers and Targeted Therapies for CSU
On the Frontlines of Chronic Spontaneous UrticariaAdvances in Biomarkers and Targeted Therapies for CSU
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Berstein, MD
Understanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses
DermConsultUnderstanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses
Charles Turck, PharmD, BCPS, BCCCP
David Cotter, MD, PhD
Charles Turck, PharmD, BCPS, BCCCP
David Cotter, MD, PhD
Tina Bhutani, MD, MAS
Tina Bhutani, MD, MAS
How Obesity Influences Psoriatic Arthritis Risk and Outcomes
Living RheumHow Obesity Influences Psoriatic Arthritis Risk and Outcomes
Philip Mease, MD, MACR
- advertisement
Clear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
CME/CE Broadcast ReplayClear Skin, Clear Path: Transforming Psoriasis Care with Durable Biologic and Oral IL-23 Innovations
Linda Stein Gold, MD
Lakshi Aldredge, MSN, ANP-BC
Najat M. Watch, PA
The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
CME/CEThe IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
Anthony Fernandez, MD, PhD
Case Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
CME/CECase Challenges in Systemic Mastocytosis: Clinical Insights From the Expert Roundtable
Carole Bitar, MD, FAAD
Matthew P. Giannetti, MD
Benjamin Ungar, MD
Calming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
CME/CECalming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
April W. Armstrong, MD, MPH
Melinda Gooderham, MSc, MD, FRCPC
Living With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
CME/CELiving With Systemic Mastocytosis: Bridging Clinical Decisions and Patient Realities
Cem Akin, MD, PhD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
CME/CEVous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
- advertisement
Addressing Adherence Challenges in Moderate-to-Severe Plaque Psoriasis Management
Medical Industry FeatureAddressing Adherence Challenges in Moderate-to-Severe Plaque Psoriasis Management
Charles Turck, PharmD, BCPS, BCCCP
Matthew Brunner, MHS, PA-C
Douglas DiRuggiero, DMSc, PA-C
Integrating Patient Perspectives in Dermatologic Care
DermConsultIntegrating Patient Perspectives in Dermatologic Care
Mona Shahriari MD, FAAD
Linda Stein Gold, MD
Jennifer Soung, MD
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry FeatureLiving with Psoriatic Arthritis: A Doctor-Patient Conversation
Elizabeth Perkins, MD
Dawn Carter
- 08/11/2026
- 08/11/2026
- 08/04/2026
- 07/31/2026
- 07/27/2026
- 07/21/2026